Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

PTC Therapeutics Inc. : PTC THERAPEUTICS PRICES INITIAL PUBLIC OFFERING

06/21/2013 | 05:03am US/Eastern

SOUTH PLAINFIELD, NJ - June 20, 2013 - PTC Therapeutics, Inc. (PTC) today announced the pricing of its initial public offering of 8,372,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the shares in the offering are being sold by PTC. In addition, the underwriters have an option for a period of 30 days to purchase up to 1,255,800 additional shares of common stock from PTC at the public offering price, less the underwriting discount. PTC's common stock has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading under the ticker symbol "PTCT" on June 20, 2013.

J.P. Morgan and Credit Suisse are acting as joint book-running managers for the offering. Cowen and Company is acting as co-lead manager and Wedbush PacGrow Life Sciences as co-manager.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on June 19, 2013.

The offering is being made only by means of a prospectus, copies of which may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717; telephone: 866-803-9204; or Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, One Madison Avenue, New York, NY 10010; telephone: 800-221-1037; email: newyork.prospectus@credit-suisse.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.

ABOUT PTC THERAPEUTICS, INC.

PTC is a biopharmaceutical company focused on the discovery and development of orally administered small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare genetic disorders and infectious diseases.

CONTACT

Jane Baj

PTC Therapeutics, Inc.

908-912-9167

jbaj@ptcbio.com

Sheryl Seapy

Pure Communications

sheryl@purecommunicationsinc.com


distributed by
React to this article
Latest news
Date Title
05:48p RADISYS : reports 2Q loss
05:48p NCR : reports 2Q loss
05:47p AMGEN : Announces 2015 Third Quarter Dividend
05:46p Twitter second-quarter revenue, adjusted profit beat estimates
05:45p Twitter second-quarter revenue, adjusted profit beat estimates
05:44p U S SENATE COMMITTEE ON FINANCE : Hatch to Hold Finance Hearing on Alternatives to Foster Care Group Homes
05:44p A M CASTLE : 07/28/15 - A. M. Castle & Co. Announces Date for Second Quarter Earnings Release - Tuesday, August 4, 2015
05:44p Iberdrola Renewables Announces Renewable Energy Sale to Riverside
05:43p CALIX : reports 2Q loss
05:43p HORACE MANN EDUCATORS : posts 2Q profit
Latest news
Advertisement
Hot News 
BANCO ESPIRITO SANTO : Release concerning the change of name of espírito santo bank
DOMINION RESOURCES BLACK WARRIOR : Announces Notification by Walter Energy of Chapter 11 Bankruptcy Filing
SOURCE BIOSCIENCE : Lab firm Select Pharma is bought for Pounds 7.3m
COLEFAX : Profit Rises As Strong Fabric Offsets Weaker Decorating Arm
ZEGONA COMMUNICATIONS : Former Virgin execs swoop for Spanish outfit
Most Read News
01:49aDJUNITED PARCEL SERVICE : UPS Earnings Surge, Gives Optimistic Guidance -- Update
10:14a RESEARCH AND MARKETS : Hepatitis A - Pipeline Review, H1 2015
07/27 RIRDC RURAL RESEARCH AND DEVELOPMENT : Quinoa shows potential for high profit crop
07/27 ITC PROPERTIES : Major Transaction in relation to the Acquisition of the Share of Westfountain Co. Ltd. and Shareholder’s Loan of its Subsidiary
07/27 MEDIA ADVISORY : Harper Government to Announce Support for Community Infrastructure in West Kelowna
Most recommended articles
05:46p Twitter second-quarter revenue, adjusted profit beat estimates
05:45p Twitter second-quarter revenue, adjusted profit beat estimates
05:43pDJWal-Mart Warns Its Suppliers Over Labeling Laws
05:40pDJZurich Insurance Considering Offer for RSA Insurance -- 4th Update
05:26pDJAnalysts Forecast No Change in Crude Stocks